Holdings
Harbor Health Care ETF
As of Jul 31, 2026, Harbor Health Care ETF reported 43 positions worth US$40.3M. Largest: Eli Lilly And Company, Ascendis Pharma A/s and Gilead Sciences, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 7,455 | US$8.56M | +1,526 | Jul 31, 2026 |
| Ascendis Pharma A/s | 22,993 | US$5.61M | +4,241 | Jul 31, 2026 |
| Gilead Sciences, Inc. | 16,135 | US$2.1M | new | Jul 31, 2026 |
| Rhythm Pharmaceuticals, Inc. | 16,680 | US$1.66M | +3,849 | Jul 31, 2026 |
| Abbvie Inc. | 5,079 | US$1.27M | −1,156 | Jul 31, 2026 |
| Intuitive Surgical, Inc. | 3,300 | US$1.17M | +573 | Jul 31, 2026 |
| Cencora, Inc. | 3,634 | US$1.13M | +1,699 | Jul 31, 2026 |
| Revolution Medicines, Inc. | 5,583 | US$1.05M | +1,037 | Jul 31, 2026 |
| Insmed Incorporated | 10,513 | US$1.04M | +3,004 | Jul 31, 2026 |
| Merck & Company, Inc. | 7,807 | US$1.02M | +2,759 | Jul 31, 2026 |